** Shares of Immuron IMC.AX rise 26.2% to A$0.082, their highest since February 28
** Biopharmaceutical co reports FY25 global annual sales of A$7.3 million ($4.75 million), up 49% on y-o-y
** "In FY26, we will invest to grow in North America" - co
** Stock on track for best day since March 2024
** About 1.1 mln shares change hands, 15.1x the 30-day average of 70,880; busiest session since January 17
** Stock up 2.5% YTD, including moves in the current session
($1 = 1.5368 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.